Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.

Literature DB >> 18625120

Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.

Moro O Salifu¹, Fasika Tedla, Serhat Aytug, Amir Hayat, Samy I McFarlane.

Abstract

New-onset diabetes after transplantation and hypertension are very common after renal transplantation and are associated with adverse graft and cardiovascular outcomes. A thorough understanding of the unique factors that operate in renal transplant recipients is essential for the proper evaluation and management of these important disorders. This review outlines the pathogenesis, diagnostic workup, and therapeutic rationale for diabetes and hypertension after transplantation.

Entities: Disease

Mesh：

Year: 2008 PMID： 18625120 DOI： 10.1007/s11892-008-0038-6

Source DB: PubMed Journal: Curr Diab Rep ISSN： 1534-4827 Impact factor: 4.810

Keyword Cloud
References

56 in total

1. Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients.

Authors: G Fernández-Fresnedo; R Escallada; A L M de Francisco; E Rodrigo; J A Zubimendi; J C Ruiz; C Piñera; I Herraez; M Arias
Journal: Transplant Proc Date: 2003-03 Impact factor: 1.066

Review 2. Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations.

Authors: P G McNally; J Feehally
Journal: Nephrol Dial Transplant Date: 1992 Impact factor: 5.992

3. Post-transplant hyperglycaemia: a study of risk factors.

Authors: Jayant T Mathew; Madhumathi Rao; Victoria Job; Selvakumar Ratnaswamy; Chakko K Jacob
Journal: Nephrol Dial Transplant Date: 2003-01 Impact factor: 5.992

4. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

Authors: N Ahsan; D Hricik; A Matas; S Rose; S Tomlanovich; A Wilkinson; M Ewell; M McIntosh; D Stablein; E Hodge
Journal: Transplantation Date: 1999-12-27 Impact factor: 4.939

Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.

1. Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients.

Review 2. Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations.

3. Post-transplant hyperglycaemia: a study of risk factors.

4. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

5. Benefits of removal of native kidneys in hypertension after renal transplantation.

Review 6. Insights Into Glucocorticoid-Associated Hypertension.

7. Efficacy and safety of Palmaz stent insertion in the treatment of renal artery stenosis in kidney transplantation.

8. Neoral rescue therapy in transplant patients with intolerance to tacrolimus.

9. Common iliac artery stenosis presenting as renal allograft dysfunction in two diabetic recipients.

Review 10. Cyclosporine-induced hypertension after transplantation.